Evaluating Efficacy of Cervical HPV-HR DNA Testing as Alternative to PET/CT Imaging for Posttreatment Cancer Surveillance: Retrospective Proof-of-Concept Study
HPV-HR DNA testing offers a cost-effective alternative to PET/CT, reducing costs, unnecessary imaging, and improving accessibility.
Authors
- Mark B. Reedy (ORCID: https://orcid.org/0000-0001-5736-193X)
- Komaraiah Palle (ORCID: https://orcid.org/0000-0002-3182-0162)
- Chinnadurai Mani (ORCID: https://orcid.org/0009-0006-0980-6555)
- Naresh Sah (ORCID: https://orcid.org/0000-0002-3657-5207)
- Kimberly J. Reese
- Cameron Huddleston
- Stephanie Stroever (ORCID: https://orcid.org/0000-0001-9683-3928)
- E. Courtney
Institutions
- Texas Tech University (US)
- Baylor Scott & White - Central Texas Foundation (US)
- Texas Tech University Health Sciences Center (US)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1158/1055-9965.epi-24-1828
- Citations
- 4
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 5.42